JTCD attenuates HF by inhibiting activation of HSCs through PPARα-TFEB axis-mediated lipophagy
{{output}}
Background: Hepatic fibrosis (HF) is an intermediate stage in the progression of chronic liver disease to cirrhosis and has been shown to be a reversible pathological process. Known evidence suggests that activation of hepatic st... ...
